On the molecular origins of the chronic myeloproliferative disorders: it all makes sense.
Kaushansky
Kenneth
K
Department of Medicine, Division of Hematology/Oncology, University of California San Diego, 402 Dickinson St, Ste 380, San Diego, CA 92103-8811, USA.
D002908:Chronic Disease; D006801:Humans; D053614:Janus Kinase 2; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000209:etiology*; D011505:Protein-Tyrosine Kinases / Q000737:chemistry / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000737:chemistry / Q000235:genetics; D017467:Receptors, Erythropoietin / Q000378:metabolism
D011518:Proto-Oncogene Proteins; D017467:Receptors, Erythropoietin; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2